Original articles

• Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry

  Aitor Uribarri, Iván J. Núñez-Gil, Álvaro Aparisi, Ramón Arroyo-Espliguero, Charbel Maroun Eid, Rodolfo Romero, Víctor M. Becerra-Muñoz, Gisela Feltes, María Molina, Marcos García-Aguado, Enrico Cerrato, Thamar Capel-Astrua, Emilio Alfonso-Rodríguez, Alex F. Castro-Mejía, Sergio Raposeiras-Roubín, Carolina Espejo, Nerea Pérez-Solé, Alfredo Bardají, Francisco Marín, Óscar Fabregat-Andrés, Fabrizio D’ascenzo, Francesco Santoro, Ibrahim Akin, Vicente Estrada, Antonio Fernández-Ortiz, Carlos Macaya, on behalf of HOPE COVID-19 investigators

  Rev Esp Cardiol. 2021;74:608-15

• Early urinary sodium trajectory and risk of adverse outcomes in acute heart failure and renal dysfunction

  Rafael de la Espriella, Eduardo Núñez, Pau Llàcer, Sergio García-Blas, Silvia Ventura, José María Núñez, Ruth Sánchez, Lorenzo Fácila, Juana María Vaquer, Vicent Bodí, Enrique Santas, Gema Miñana, Anna Mollar, Gonzalo Núñez, Francisco J. Chorro, José L. Górriz, Juan Sanchis, Antoni Bayés-Genis, Julio Núñez

  Rev Esp Cardiol. 2021;74:616-23

• Outcomes after complete dissolution of everolimus-eluting bioresorbable scaffolds implanted during routine practice

  Jens Wiebe, Petra Hoppmann, Salvatore Cassese, Tobias Rheude, Roisin Colleran, Constantin Kuna, Himanshu Rai, Michael Valeskini, Tareq Ibrahim, Michael Joner, Heribert Schunkert, Karl-Ludwig Laugwitz, Adnan Kastrati, Robert A. Byrne

  Rev Esp Cardiol. 2021;74:584-90

• Spanish registry of percutaneous VSD closure with NitOcclud Lê VSD Coil device: lessons learned after more than a hundred implants

  Ruth Solana-Gracia, Alberto Mendoza Soto, José Ignacio Carrasco Moreno, María Jesús del Cerro Marín, Federico Gutiérrez-Larraya Aguado, José Félix Coserría Sánchez, Roberto Blanco Mata, Fredy Hermógenes Prada Martínez, Manuel Pan Álvarez-Ossorio, Lorenzo Jiménez Montañés, Armando Pérez de Prado, María del Mar Rodríguez Vázquez del Rey, Hipólito Gutiérrez García, José Manuel Velasco Bayón, José Luis Zunzunegui Martínez

  Rev Esp Cardiol. 2021;74:591-601

• Markers of myocardial injury in the prediction of short-term COVID-19 prognosis

  Alicia Calvo-Fernández, Andrea Izquierdo, Isaac Subirana, Nuria Farré, Joan Vila, Xavier Durán, Marcos García-Guimaraes, Sandra Valdivielso, Paula Cabero, Cristina Soler, Cora García-Ribas, Clara Rodríguez, Marc Llagostera, Diana Mojón, Miren Vicente, Eduard Solé-González, Andrea Sánchez-Carpintero, Cristina Tevar, Jaume Marrugat, Beatriz Vaquerizo

  Rev Esp Cardiol. 2021;74:576-83

• Reasons for refusing diagnostic tests and therapeutic recommendations and associated complications in inherited heart diseases. The RELUCTANT study

  David López Cuenca, María Orenes Moreno, M. Carmen Olmo Conesa, Antonio Pastor Moreno, Juan José Santos Mateo, Carmen Muñoz Esparza, Marina Navarro Peñalver, Francisco José Castro García, María Sabater Molina, Juan Ramón Gimeno Blanes

  Rev Esp Cardiol. 2021;74:526-32

• Noninferiority of heart failure nurse titration versus heart failure cardiologist titration. ETIFIC multicenter randomized trial

  Juana Oyanguren, Lluisa Garcia-Garrido, Magdalena Nebot-Margalef, Pedro Latorre-García, Jesús Torcal-Laguna, Josep Comín-Colet, Julia Roure, José González-Costello, Nicolás Manito, José M. García-Pinilla, Yolanda Sánchez-Paule, Alfonso Varela-Román, María Moure, Javier Segovia-Cubero, Teresa Soria, Eunate Arana-Arri, Iñaki Lekuona, Steering Committee on behalf of the ETIFIC research team group

  Rev Esp Cardiol. 2021;74:533-43

• Feasibility and results of an intensive cardiac rehabilitation program. Insights from the MxM (Más por Menos) randomized trial

  Almudena Castro-Conde, Manuel Abeytua, Vicente I. Arrarte Esteban, Pedro Caravaca Pérez, Regina Dalmau González-Gallarza, Fernando Garza Benito, Rafael J. Hidalgo Urbano, Joan Torres Marqués, Rafael Vidal-Pérez, Iván J. Nuñez-Gil

  Rev Esp Cardiol. 2021;74:518-25

• New-onset heart failure after acute coronary syndrome in patients without heart failure or left ventricular dysfunction

  Alberto Cordero, Moisés Rodríguez-Mañero, Vicente Bertomeu-González, José M. García-Acuña, Aurora Baluja, Rosa Agra-Bermejo, Belén Álvarez-Álvarez, Belén Cid, Pilar Zuazola, José R. González-Juanatey

  Rev Esp Cardiol. 2021;74:494-501

• Early kinetics of cardiac troponin in suspected acute myocardial infarction

  María Rubini Giménez, Karin Wildi, Desiree Wussler, Luca Koechlin, Jasper Boeddinghaus, Thomas Nestelberger, Patrick Badertscher, Raphael Sedlmayer, Christian Puelacher, Tobias Zimmermann, Jeanne du Fay de Lavallaz, Pedro Lopez-Ayala, Kathrin Leu, Katharina Rentsch, Òscar Miró, Beatriz López, F. Javier Martín-Sánchez, José Bustamante, Damian Kawecki, Jiri Parenica, Jens Lohrmann, Wanda Kloos, Andreas Buser, Dagmar I. Keller, Tobias Reichlin, Raphael Twerenbold, Christian Mueller

  Rev Esp Cardiol. 2021;74:502-9

• Differences in in-hospital mortality after STEMI versus NSTEMI by sex. Eleven-year trend in the Spanish National Health Service

  Luis Rodríguez-Padial, Cristina Fernández-Pérez, José L. Bernal, Manuel Anguita, Antonia Sambola, Antonio Fernández-Ortiz, Francisco J. Elola

  Rev Esp Cardiol. 2021;74:510-7

• Chronic thromboembolic pulmonary hypertension in Spain: a decade of change

  Paula Martínez-Santos, María Teresa Velázquez-Martín, Joan Albert Barberá, Cristina Fernández Pérez, Manuel López-Meseguer, Raquel López-Reyes, Amaya Martínez-Meñaca, Antonio Lara-Padrón, Juan Antonio Domingo-Morera, Isabel Blanco, Pilar Escribano-Subías, on behalf of REHAP investigators

  Rev Esp Cardiol. 2021;74:384-92

• Sudden cardiac death in persons aged 50 years or younger: diagnostic yield of a regional molecular autopsy program using massive sequencing

  Tomás Ripoll-Vera, Consuelo Pérez Luengo, Juan Carlos Borondo Alcázar, Ana Belén García Ruiz, Nieves Sánchez Del Valle, Bernardino Barceló Martín, Juan Luis Poncela García, Gloria Gutiérrez Buitrago, Concepción Dasi Martínez, Juan Carlos Canós Villena, Susana Moyano Corvillo, Raquel Esgueva Pallarés, Juan Ramón Sancho Sancho, Gemma Guitart Pinedo, Elena Hernández Marín, Estela García García, Albert Vingut López, Jorge Álvarez Rubio, Nancy Govea Callizo, Yolanda Gómez Pérez, Catalina Melià Mesquida, Damián Heine, Jordi Rosell Andreo, Lorenzo Socías Crespí

  Rev Esp Cardiol. 2021;74:402-13

• Impact of donor-recipient age on cardiac transplant survival. Subanalysis of the Spanish Heart Transplant Registry

  Raquel López-Vilella, Francisco González-Vílchez, María G. Crespo-Leiro, Javier Segovia-Cubero, Manuel Cobo, Juan Delgado-Jiménez, José María Arizón del Prado, Manuel Martínez-Sellés, José Manuel Sobrino Márquez, Sonia Mirabet-Pérez, José González-Costello, Félix Pérez-Villa, José Luis Lambert-Rodríguez, Gregorio Rábago-Aracil, María Teresa Blasco-Peiró, Luis de la Fuente-Galán, Iris Garrido-Bravo, Déborah Otero, Luis Almenar-Bonet

  Rev Esp Cardiol. 2021;74:393-401

• Analysis of the dose-response relationship of leisure-time physical activity to cardiovascular disease and all-cause mortality: the REGICOR study

  Albert Clará, Georgina Berenguer, Silvia Pérez-Fernández, Helmut Schröder, Rafel Ramos, María Grau, Irene R. Dégano, Alba Fernández-Sanlés, Jaume Marrugat, Roberto Elosua

  Rev Esp Cardiol. 2021;74:414-20

• Influence of neoatherosclerosis on prognosis and treatment response in patients with in-stent restenosis

  Nieves Gonzalo, Carlos H. Salazar, María José Pérez-Vizcayno, Juan Carlos Gómez-Polo, Pilar Jiménez-Quevedo, Santiago Jiménez-Valero, Monica Masotti, Rafael Romaguera, Antonio Fernández-Ortiz, Javier Escaned, Fernando Alfonso, Carlos Macaya

  Rev Esp Cardiol. 2021;74:427-35

• Impact of renin-angiotensin system inhibitors on outcomes after surgical or transcatheter aortic valve replacement. A meta-analysis

  Ignacio J. Amat-Santos, Sandra Santos-Martínez, Fabián Julca, Pablo Catalá, Tania Rodríguez-Gabella, Alfredo Redondo-Diéguez, Williams Hinojosa, Carlos Veras, Alberto Campo, Ana Serrador Frutos, Manuel Carrasco-Moraleja, José A. San Román

  Rev Esp Cardiol. 2021;74:421-6

• Predictors of adoption and impact of evidence-based programming on the incidence of implantable cardioverter-defibrillator therapies

  Gerard Loughlin, Tomás Datino, Ángel Arenal, Ricardo Ruiz-Granell, Juan Miguel Sánchez-Gómez, Luisa Pérez, José Martínez-Ferrer, Javier Alzueta, Fernando Pérez-Lorente, Xavier Viñolas, María Luisa Fidalgo Andrés, Joaquín Fernández de la Concha

  Rev Esp Cardiol. 2021;74:296-302

• Validation of the usefulness of 2-dimensional strain parameters to exclude acute rejection after heart transplantation: a multicenter study

  Josebe Goirigolzarri Artaza, Susana Mingo Santos, José María Larrañaga, Ana Osa, Mario Sutil-Vega, Martín Ruiz Ortiz, Cecilia Corros, Bárbara Vidal, Vanessa Moñivas Palomero, Nicolás Maneiro, Cayetana María Barbeito, Raquel López-Vilella, Chi-Hion Li, Sara Rodríguez Diego, José Luis Lambert, Franciris Velásquez, María G. Crespo-Leiro, Luis Almenar, Sonia Mirabet, Alejandro Martínez Mingo, Javier Segovia Cubero

  Rev Esp Cardiol. 2021;74:337-44

• Time course and predictors for neoaortic root dilatation and neoaortic valve regurgitation during adult life after arterial switch operation

  Joaquín Rueda Soriano, María José Rodríguez Puras, Francisco Buendía Fuentes, Amadeo Wals Rodríguez, Ana Osa Sáez, Ildefonso Pulido, Jaime Agüero Ramón-Llin, Begoña Manso García, Beatriz Insa Albert, Silvia Navarro, Luis Martínez-Dolz, Pastora Gallego

  Rev Esp Cardiol. 2021;74:329-36